Product Overview
CJC-1295 is a synthetic analog of growth hormone releasing hormone (GHRH) engineered to enhance molecular stability and prolong activity in experimental systems. The peptide incorporates structural modifications designed to increase resistance to enzymatic degradation and enable sustained receptor interaction within laboratory research models. In preclinical settings, CJC-1295 is commonly utilized to investigate growth hormone regulatory pathways and endocrine signaling dynamics under controlled experimental conditions.
Within laboratory environments, CJC-1295 functions as a molecular tool for studying GHRH receptor activation, growth hormone secretion patterns, and downstream signaling cascades associated with endocrine regulation. Scientific publications describe its application in examining hormone release dynamics, receptor mediated intracellular signaling, and feedback mechanisms governing hypothalamic pituitary axis function in cellular and animal research models. CJC-1295 is widely referenced in scientific literature examining peptide mediated endocrine communication and hormonal signaling pathways in non clinical experimental systems. Observations related to receptor interactions, signaling responses, and hormonal modulation are derived exclusively from in vitro and animal research models and are reported as descriptive findings within controlled investigative research contexts.
Storage & Handling
Molecular Information
Quality Assurance
Every batch undergoes comprehensive third-party testing
HPLC Analysis
High-Performance Liquid Chromatography confirms peptide purity and identity
Mass Spectrometry
Molecular weight verification through advanced mass spec analysis
Endotoxin Testing
LAL assay confirms endotoxin levels meet strict specifications